Addressing Health Risks in Patients with Peripheral Arterial Disease and Diabetic Neuropathies PHILADELPHIA, July 22, 2020 /PRNewswire/ — Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a global leader in the development of clinically validated cannabis medicines, is pleased to announce it has entered into a […]
